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THP-1 monocytesHigh levels of viremia and chemokines and cytokines underlie the progression of severe dengue disease.
Dengue virus (DENV) preferentially infects peripheral blood monocytes, which secrete elevated levels of
immunomediators in patients with severe disease. Further, DENV nonstructural proteins (NS) are capable of
modifying intracellular signaling, including interferon inhibition. We demonstrate that peak secretions of
immunomediators such as IL-6, IL-8, IP-10, TNFα or IFNγ in DENV-infected monocytes correlate with
maximum virus production and NS4B and NS5 are primarily responsible for the induction of immunome-
diators. Furthermore, we demonstrate that sequential NS4AB processing initiated by the viral protease NS2B3
(pro) and via the intermediate 2KNS4B signiﬁcantly enhances immunomediator induction. While the 2K-
signal peptide is not essential for immunomediator induction, it plays a synergistic role with NS4B. These data
suggest that NS4B maturation is important during innate immune signaling in DENV-infected monocytes.
Given similar NS4B topologies and polyprotein processing across ﬂaviviruses, NS4B may be an attractive
target for developing Flavivirus-wide therapeutic interventions.dicine, University of Hawaii at
, USA. Fax: +1 808 692 1984.
).
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Dengue virus (DENV) causes considerable risk to human health
worldwide infecting an estimated 50–100 million people annually
and causing explosive outbreaks with infection rates as high as
80–90% among individuals previously unexposed to the virus
(World Health Organization, 1997). The incidence of dengue
diseases has dramatically increased during the past two decades
as the result of an expanding geographical distribution of the
Aedes mosquito vector and increased human travel (Gubler, 2002;
Gubler, 2006; World Health Organization, 1997). Over 90% of
DENV infections are asymptomatic or result in self-limiting
dengue fever (DF) cases that resolve without complications
(Guzman and Isturiz, 2010; Guzman and Kouri, 2002). However,
a subset of infected patients progresses to severe dengue
hemorrhagic fever (DHF) and dengue shock syndrome (DSS),
resulting in over a half-million hospitalizations each year world-
wide (Gubler, 1998; World Health Organization, 2009). No
deﬁnitive mechanisms explain the progression of DHF/DSS,
which can be deﬁned in part as bleeding and increased plasma
leakage into the pleural cavities and peripheral tissue without
morphological damage to the capillary endothelium (Chang et al.,
1990; Srikiatkhachorn et al., 2007). Clinical studies indicate thatpatients who progress to severe disease demonstrate elevated
viremia (Libraty et al., 2002; Murgue et al., 2000; Vaughn et al.,
2000) and high levels of interleukin (IL)-6, IL-8 and tumor
necrosis factor alpha (TNFα) in the bloodstream (Hober et al.,
1993; Huang et al., 2000; Juffrie et al., 2001; Nguyen et al., 2004;
Priyadarshini et al., 2010; Raghupathy et al., 1998). Similarly,
peripheral blood monocytes from patients with DHF/DSS display
elevated DENV antigen and increased expression of activation
markers and production of immunomediators (Durbin et al., 2008;
Halstead, 1989; Kou et al., 2008), implicating monocytes as
important cells during infection and severe disease pathogenesis.
Moreover, DENV-infected primary monocytes secrete DHF/DSS-
associated immunomediators (Bosch et al., 2002; Chen and Wang,
2002).
DENV belongs to the family Flaviviridae and consists of four
genetically distinct serotypes having a positive-sense, single-
stranded RNA genome of approximately 11 kilobases (kb) in
length. The RNA encodes for a polyprotein precursor that is co-
and post-translationally processed into three structural (C, PrM
and E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3,
NS4A, NS4B and NS5) (Bell et al., 1985; Chambers et al., 1990). The
NS are responsible for various enzymatic activities during
replication, including the NS5 RNA-dependent RNA polymerase
(RdRP) and methyltransferase activity required for viral RNA
capping (Chung et al., 2010; Dong et al., 2010; Geiss et al., 2009;
Selisko et al., 2010; Zou et al., 2011), the NS3 helicase and the
NS2B3 protease (NS2B3pro) (Cahour et al., 1992; Falgout et al.,
28 J.F. Kelley et al. / Virology 418 (2011) 27–391991; Padmanabhan et al., 2006). Several NS, such as NS3, NS4B
and NS5, interact as part of the viral replication complex
facilitating transcription and translation of the viral genome
(Harris et al., 2006; Khromykh et al., 1999a; Khromykh et al.,
1999b; Mackenzie et al., 2007; Roosendaal et al., 2006; Westaway
et al., 1997a; Westaway et al., 1997b). Further, accumulating
evidence suggests that intrinsic DENV genetic characteristics
within NS4B and NS5 are associated with severe disease outcomes
(Leitmeyer et al., 1999).
DENV NS5 induces IL-8 transcription and protein secretion in
human embryonic kidney cells, (Medin et al., 2005) and inhibits the
interferon alpha (IFNα) response through binding and degradation of
STAT2 (Ashour et al., 2009; Mazzon et al., 2009). Also, NS4B strongly
inhibits the IFN transduction cascade by interfering with STAT1
phosphorylation (Munoz-Jordan et al., 2003); and sequential proces-
sing of NS4AB by viral and host proteases is required to initiate an IFN
antagonistic function (Munoz-Jordan et al., 2005). Nonstructural
protein-induced subversion of the host IFN response and induction of
immunomediators may simultaneously promote DENV survival while
increasing the risk of severe disease outcomes. Based on the
aforementioned data, to further understand the role of NS in dengue
immunopathogenesis, we hypothesized that NS5 and maturation of
NS4B expressed in monocytes would induce DHF-associated
immunomediators. In this report, we demonstrate that both NS5
and NS4B induce immunomediators and that NS4B maturation
via cleavage of the NS4AB polypeptide, in a 2KNS4B-dependent
manner, signiﬁcantly enhanced immunomediator production in
monocytes.Fig. 1. Kinetics of chemokine and cytokine secretion in DENV-infected THP-1 cells. THP-1 ce
were collected every 24 h after infection for ﬁve consecutive days. (A) Viral titers and RNA c
collected each day after infection (MOI-1, solid line; MOI-0.1, dotted line). (B) Chemokine an
at days 1 and 3 after infection (mock-infected, white bars; DENV-infected MOI-0.1, light g
points and bars represent the mean±SD of three independent experiments conducted in du
N.D., not detected.Results
Elevated secretion of immunomediators from DENV-infected THP-1
monocytes corresponds with peak viral titers and copy numbers
To establish whether DENV-infected monocytes secrete DHF-associ-
ated immunomediators, we infected THP-1 cells with DENV-2 New
Guinea (NGC) strain and collected cells and culture supernatants eachday
for ﬁve consecutive days. Plaque assay and quantitative real-time
polymerase chain reaction (qRT-PCR) data demonstrated that peak viral
titers and copy numbers for both MOI-0.1 and -1 occurred on day 3 after
infection; however, infection with MOI-1 resulted in approximately log
1.4 higher titer and log0.5 higher viral RNA transcripts than infectionwith
anMOI-0.1 on day 3 after infection (Fig. 1A). We determined by qRT-PCR
that thepeak inductionof IL-8andTNFα transcriptsoccurredatday3after
infection (Supplemental Fig. 1); therefore, we assayed the THP-1
supernatants for immunomediators at days 1 and 3 after infection. The
Luminex® multiplex data corresponded with transcript data in that the
THP-1 cells infected with an MOI-1 induced peak secretion of IL-6, IL-8,
interferon gamma-induced protein 10 (IP-10) and TNFα at day 3 after
infection (Fig. 1B). Levels of IL-6, IL-8, IP-10, and TNFα peaked at 52, 2000,
40 and65 pg/mL, respectively. Also slight overall increaseswere observed
inVEGFand IFNγ levels at day3 after infection. THP-1 cells incubatedwith
lipopolysaccharide (LPS) signiﬁcantly produced all of the immunomedia-
tors tested both at the transcript and protein levels (Supplemental Fig. 1
and Fig. 1B) whereas THP-1 cells mock-infected with UV-treated virus
produced low expression levels similar to those observed in untreated
THP-1 cells (Fig. 1B). Overall, these results demonstrated that DENV-2lls were infected with DENV-2 NGC strain at MOI-0.1 and -1 and cells and supernatants
opy numbers were determined by plaque assay and qRT-PCR, respectively, on samples
d cytokine levels in mock- and DENV-infected THP-1 cell culture supernatants collected
ray bars; DENV-infected MOI-1, dark gray bars; and LPS treatment, striped bars). Data
plicate. (*) indicates statistical signiﬁcance at pb0.05 as compared to same day controls;
Fig. 2. Expression of nonstructural DENV-V5 fusion protein constructs in THP-1 cells. THP-1 cells were transfected with each DENV nonstructural gene plasmid and cell lysates were
collected at 40 h after transfection for expression analysis by qRT-PCR and western blot. (A) Constructs and approximate nucleotide number (kb) of cloned viral genes. Each gene
was constructed using a V5 reporter vector having the CMV promoter for expression in mammalian cells. (B) V5 copy numbers were determined for each expressing plasmid using
qRT-PCR and reported as log of V5 mRNA transcripts per μg of RNA. A standard curve was prepared by serially diluting known amount of V5 transcripts. (C) Western blot analysis of
DENV-V5 proteins expression. Twenty microliter (approximately 50 μg) of each cell lysate was loaded and electrophoresed on SDS-PAGE followed by immunoblotting with V5
antibody. Protein loading amounts were conﬁrmed using β-actin and a relative intensity (RI) was calculated by dividing the absolute intensity of the DENV-V5 protein band by the
absolute intensity of its corresponding β-actin band. The cell lysate loaded in each well is speciﬁed at the top and its corresponding molecular mass (kDa) is depicted at the left or
right. Bars represent the mean±SD of three independent experiments conducted in duplicate. No signiﬁcant differences (pb0.05) were found across transcripts.
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and that maximum transcript expression and protein secretion levels
corresponded with peak viral titers and copy numbers. These data are
consistentwithother in-vitrodatademonstrating that infectedTHP-1cells
secrete elevated chemokines and cytokines, which corresponds with
increased viral titers (Chareonsirisuthigul et al., 2007; Hober et al., 1996;
Ubol et al., 2008).
NS4B or NS5 expressed in THP-1 cells induces IL-6, IL-8 and IP-10
To evaluate the role of DENV NS on the observed induction of
immunomediators, we constructed plasmids (Fig. 2A) with a
commercially available V5 expression vector using primers
designed from the wild-type NGC genome (Table 1). Following the
manufacturer's optimization instructions for the Neon™ system, we
determined that maximum expression levels of the V5 control
plasmid or NS5-V5 plasmid and THP-1 cell viability (approximately
70% for all plasmids) occurred at 40 h after transfection (Supple-
mental Fig. 2). Therefore, successful expression of each DENV
plasmid was conﬁrmed at 40 h after transfection by immunoﬂuo-
rescence assay (data not shown), qRT-PCR and western blot (Figs.
2B–C). We conducted qRT-PCR using primers designed to detect
plasmid expressing V5 mRNA (Table 2) and demonstrated similar
mRNA expression levels, wherein approximately log 4.25 copies of
transcripts were expressed by all DENV-V5 fusion plasmids with no
signiﬁcant difference between the minimum (NS4B) and maximumTable 1
Primers employed for the construction of DENV gene plasmids.
Construct and primer namesa Nucletide positionb Primer sequence (5′–3′)c
NS1
NS1-forward (F) 2422–2443 accaccatgGATAGTGGTTGCGTTGT
NS1-reverse (R) 3477–3449 GGCTGTGACCAAGGAGTTGACCAA
NS2A
NS2A-F 3478–3499 accaccatgGGACATGGGCAGATTGA
NS2A-R 4131–4102 CCTTTTCTTGTTGGTTCTTGAAAGG
NS2B
NS2B-F 4132–4149 accaccatggctAGCTGGCCACTAAAT
NS2B-R 4521–4995 CCGTTGTTTCTTCACTTCCCACAGGT
NS2AB
NS2A-F 3478–3499 accaccatgGGACATGGGCAGATTGA
NS2B-R 4521–4995 CCGTTGTTTCTTCACTTCCCACAGGT
NS2B3(pro)
NS2B-F 4132–4149 accaccatggctAGCTGGCCACTAAAT
NS3pro-R 5064–5035 GTCATCTTCGATCTCTGGATTGTCTT
NS3
NS3-F 4522–4543 accaccatgGCTGGAGTATTGTGGGA
NS3-R 6375–6348 CTTTCTTCCAGCTGCAAACTCCTTGA
NS4A
NS4A-F 6376–6393 accaccatggctTCCCTGACCCTGAACC
NS4A-R 6825–6800 TGCCATGGTTGCGGCCACCACTGTG
NS4A(-2K)
NS4A-F 6376–6393 accaccatggctTCCCTGACCCTGAACC
NS4A(-2K)-R 6756–6731 TCTCTGTTTTTCTGGTTCTGGAATAA
NS4B
NS4B-F 6826–6846 accaccatggctAACGAGATGGGTTTC
NS4B-R 7569–7540 CCTTCTCGTGTTGGTTGTGTTCTTCA
NS4AB
NS4A-F 6376–6393 accaccatggctTCCCTGACCCTGAACC
NS4B-R 7569–7540 CCTTCTCGTGTTGGTTGTGTTCTTCA
NS4B-GFP-R 7569–7540 gCCTTCTCGTGTTGGTTGTGTTCTTC
2KNS4B
2KNS4B-F 6757–6777 accaccatggctACACCCCAAGATAAC
NS4B-R 7569–7540 CCTTCTCGTGTTGGTTGTGTTCTTCA
NS5
NS5-F 7570–7591 accaccatgGGAACTGGCAACATAGG
NS5-R 10,269–10,239 CCACAGGACTCCTGCCTCTTCCTCTT
a Forward, sense sequence; reverse, antisense sequence.
b Determined from NCBI accession number M29095 (DENV NGC strain).
c Kozac sequence shown as bold lower-case letters, ﬁll-in nucleotides for in-frame transl(NS5) expression levels (p=0.32) (Fig. 2B). Also, we conducted
western blot and demonstrated similar relative intensities (RIs),
calculated as described in Materials and methods, for all DENV
proteins, wherein NS1 reached a maximum RI of 1.11 and NS2B3
(pro) reached a minimum RI of 0.92 (Fig. 2C). Having established
similar transcript and protein expression levels for all DENV
plasmids at 40 h after electroporation, we screened transfected
cells for immunomediator induction using qRT-PCR. We demon-
strated that NS4B signiﬁcantly increased IL-6 transcripts approxi-
mately 4-fold and IL-8 almost 9-fold relative to NS4AB (Fig. 3).
Moreover, NS5 signiﬁcantly increased IL-6 transcripts approximate-
ly 8-fold and IL-8 over 11-fold relative to NS4AB (Fig. 3). However,
relative to NS4AB expression NS4B (p=0.07) or NS5 (p=0.09) did
not signiﬁcantly increase TNFα transcripts levels (Fig. 3).
Given that NS4B and NS5 induced DHF-associated immunome-
diator transcripts, we examined the culture supernatant for
secreted immunomediators induced by NS4B, NS5 and the viral
replication complex-associated proteins NS2B3(pro), NS3 and
NS4AB. As an alternative method to conﬁrm plasmid expression
efﬁciencies, we conducted ﬂow cytometry using a V5 antibody to
detect each DENV-V5 fusion protein (Fig. 4A). We observed similar
protein levels for all plasmids tested wherein a range of 12–18% of
THP-1 cells expressed DENV-V5 fusion proteins (Fig. 4A). Having
established similar NS-V5 transcript and protein expression levels
by qRT-PCR, western blot and ﬂow cytometry, we quantitated
secreted immunomediator levels in the culture supernatants usingTm (°C) Amplicon size
(bp)
PCR cycling conditions
GAGCT 65.9 1056 95 °C 5 min 1 cycle; 95 °C 45 s, 57 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1cycleATTCT 62.3
CAACT 66.1 654 95 °C 5 min 1 cycle; 95 °C 30 s, 55 °C 30 s,
72 °C 45 s, 30 cycles; 72 °C 7 min 1 cycleGTTGT 59.6
GAG 64.9 390 95 °C 5 min 1 cycle; 95 °C 30 s, 55 °C 30 s,
72 °C 45 s, 30 cycles; 72 °C 7 min 1 cycleA 60.5
CAACT 66.1 1044 95 °C 5 min 1 cycle; 95 °C 45 s, 55 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleA 60.5
GAG 64.9 933 95 °C 5 min 1 cycle; 95 °C 45 s, 53 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleCAAT 58.1
TGTCC 66.0 1854 95 °C 5 min 1 cycle; 95 °C 45 s, 55 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleAT 59.5
TA 64.1 450 95 °C 5 min 1 cycle; 95 °C 30 s, 59 °C 30 s,
72 °C 45 s, 30 cycles; 72 °C 7 min 1 cycleA 68.6
TA 64.1 381 95 °C 5 min 1 cycle; 95 °C 30 s, 59 °C 30 s,
72 °C 45 s, 30 cycles; 72 °C 7 min 1 cycle59.3
CTGGAA 66.4 744 95 °C 5 min 1 cycle; 95 °C 45 s, 55 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleTGAT 60.5
TA 64.1 1194 95 °C 5 min 1 cycle; 95 °C 45 s, 55 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleTGAT 60.5
ATGAT 60.5
CAATTG 64.4 813 95 °C 5 min 1 cycle; 95 °C 45 s, 55 °C 45 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleTGAT 60.5
AGAGA 65.2 2700 95 °C 5 min 1 cycle; 95 °C 1 min, 59 °C 60 s,
72 °C 1 min, 30 cycles; 72 °C 7 min 1 cycleCTTTT 64.0
ation as lower case letters and DENV sequence as upper-case letters.
Table 2
Primers employed for the analysis of DENV and host genes by qRT-PCR.
Gene and primer namesa Primer sequence (5′–3′) Tm (°C) Amplicon size (bp)
DENV2 capsidb
DN-forward (F) CAATATGCTGAAACGCGAGAG 55.8 167
DN-reverse (R) CATCTATTCAGAATCCCTGCT 58.3
V5 epitopeb
V5-F TCTGCAGATATCCAGCACAGT 55.8 87
V5-R ACCGAGGAGAGGGTTAGGGAT 59.2
GAPDHc
GAPDH-F AGTTAGCCGCATCTTCTTTTGC 56.1 100
GAPDH-R CAATACGACCAAATCCGTTGAC 55.3
IL-6c
IL6-F CCAGGAGCCCAGCTATGAAC 57.8 63
IL6-R CCCAGGGAGAAGGCAACTG 58.2
IL-8c
IL8-F GAACTGAGAGTGATTGAGAGT 55.1 133
IL8-R CTCTTCAAAAACTTCTCCACA 56.6
IP-10c
IP10-F CCACGTGTTGAGATCATTGC 54.3 139
IP10-R GCTCCCCTCTGGTTTTAAGG 55.4
TNF-αc
TNFα-F CCCAGGGACCTCTCTCTAATCA 55.9 79
TNFα-R GCTACAGGCTTGTCACTCGG 58.6
a Forward, sense sequence; reverse, antisense sequence.
b Real-time PCR primers used to determine DENV2 NGC and V5 copy numbers.
c Real-time RT-PCR primers to amplify immunomediator genes.
31J.F. Kelley et al. / Virology 418 (2011) 27–39the Luminex® technology. As expected, NS4B or NS5 signiﬁcantly
induced IL-6, IL-8, IP-10 and IFNγ when compared to cells
expressing only the V5 epitope (Fig. 4B). Cells expressing NS4B
secreted 57, 1100 and 48 pg/mL of IL-6, IL-8 and IP-10, respec-
tively, while cells expressing NS5 secreted slightly higher levels of
these immunomediators (Fig. 4B). NS4B and NS5 increased TNFα
production but the difference was not signiﬁcant, p=0.11 and
0.08, respectively. However, DENV-infected or LPS-treated cells
signiﬁcantly induced TNFα (Fig. 1B) indicating an alternative
route of induction. When we electroporated the THP-1 cells
without plasmid DNA (pDNA) or the V5 vector control, we
observed chemokine and cytokine expression levels similar toFig. 3. DENV NS4B and NS5 induce IL-6, IL-8, and TNFα transcripts in THP-1 cells. THP-1
cells expressing individual DENV nonstructural genes were harvested at 40 h after
transfection and total mRNA was isolated for immunomediator transcript analysis by
qRT-PCR. The fold change induction of IL-6, IL-8, and TNFα transcripts was determined
for each DENV gene relative to V5 controls. LPS was used as a positive control and
GAPDH was used as the endogenous control. Bars represent the mean±SD of three
independent experiments conducted in duplicate. (*) indicates statistical signiﬁcance at
pb0.05 as compared to transcript levels induced by the NS4AB-V5 fusion protein.endogenous THP-1 levels (Fig. 4B and data not shown). Cell
viability reached approximately 70% at 40 h after treatment,
including the no-plasmid transfected and LPS-treated control
cells (Supplemental Fig. 2), further indicating that the differences
observed were due to the expression of NS4B and NS5.
Maturation of NS4B via cleavage of NS4AB enhances IL-6 and IL-8
production
During replication, the DENV protease NS2B3(pro) interacts with the
NS4AB polyprotein presumably as part of the viral replication complex.
Previousworkhasdemonstrated sequential processing ofNS4ABwherein
NS2B3(pro) cleaves NS4AB, releasing NS4A from NS4B (Cahour et al.,
1992; Miller et al., 2006). We proposed that expressing both NS4AB and
NS2B3(pro) in THP-1 cells would best mimic natural processing and
maturation of NS4B and possibly affect the immunomediator induction
pattern observed during the expression of individual viral proteins. To
detect THP-1 cells expressing both NS4AB and NS2B3(pro), we
constructed the NS4AB-GFP fusion protein plasmid (Fig. 5A) for co-
expression with the NS2B3(pro)-V5 fusion protein. We demonstrated by
ﬂow cytometry that approximately 9% of electroporated THP-1 cells co-
expressed NS4AB-GFP and NS2B3(pro)-V5, 23% expressed NS4AB-GFP
and 12, 14 and 17% expressedNS4B, NS2B3(pro) andNS5, respectively, at
40 h after electroporation (Fig. 5B). To conﬁrm the ﬂow cytometry data
andexamine functional cleavageevents,we conductedwesternblot using
cells co-expressing NS4AB and the viral protease NS2B3(pro). As
expected, we observed that the co-expression resulted in the cleavage
of NS4AB which produced four distinct bands: NS4AB, NS2B3(pro),
2KNS4B and NS4B (Fig. 5C). Co-expression of NS4AB and NS2B3(pro)
signiﬁcantly enhanced the induction of IL-6 and IL-8 transcripts when
compared to NS4B or NS5 alone, approximately doubling the relative fold
change of IL-6 transcripts from 4- to 8-fold and IL-8 transcripts from 9- to
18-fold (Fig. 5D). Given that NS4B co-localizes with NS3 and NS5 during
IFN antagonistic function and as part of the viral replication complex
(Mazzon et al., 2008;Miller et al., 2006; Umareddy et al., 2006), we tested
the induction potential of NS4B with NS3 or NS5 and demonstrated that
the induction potentialwas unaltered relative toNS4B orNS5 alone for IL-
6 or IL-8 (data not shown), further supporting our results that
enhancement occurs primarily during NS4B maturation and polyprotein
Fig. 4. DENV NS4B and NS5 induce DHF-associated immunomediators in THP-1 cells. THP-1 cells were electroporated with DENV NS and after 40 h, cells and supernatants were
collected to measure expression efﬁciencies and immunomediator protein levels, respectively. (A) Percent of THP-1 cells expressing DENV-V5 fusion proteins as determined by ﬂow
cytometry. Cells were ﬁxed, permeabilized and V5-expression proteins were detected using an anti-V5 primary antibody and Alexa Fluor® 594 secondary antibody. (B) Chemokine
and cytokine levels (pg/mL) in the supernatants of THP-1 cells expressing NS at 40 h after electroporation and as determined by the Luminex®multiplex technology. Bars represent
the mean±SD of three independent experiments conducted in duplicate and (*) indicates statistical signiﬁcance at pb0.05 as compared to vector controls.
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enhance the inductionof IP-10, suggesting thatmultiplepathwaysmaybe
responsible for inducing immunomediators. Although this result is
unexpected, signal transduction crosstalk is regulated in a dynamic
manner and may differ under homeostatic and pathologic conditions
making it difﬁcult to determine the exact mechanisms responsible for
induction outcomes (Hu et al., 2007). However, taken together these
results suggest that NS4AB expressed with NS2B3(pro) initiates sequen-
tialprocessingofNS4ABandmaturationofNS4B(Miller et al., 2007;Miller
et al., 2006), thereby enhancing the induction of immunomediators.
Expression of the 2K-signal peptide with NS4B is sufﬁcient to enhance IL-
6 and IL-8 induction
TheDENV2K-signal sequence is a 17-amino acidpeptide linkingNS4A
with NS4B and has little known function. Having observed the cleavage
product 2KNS4B in the co-transfected cells, we questioned whether the2K-signal sequencewas responsible for the observed enhanced induction
of immunomediator transcripts. To address this question, we constructed
the plasmids 2KNS4B and NS4A without 2K (-2K) (NS4A-2K) (Fig. 6A)
and expressed them alone or in combination with other NS, particularly
NS2B3(pro) due to its intrinsic enzymatic properties and involvement in
the replication complex. By using qRT-PCR and western blot, we
demonstrated the production of approximately log 4 copies of V5
mRNA transcripts by each plasmid or combination of plasmids (Fig. 6B)
and cleavage of 2KNS4B, respectively (Fig. 6C). Importantly, 2KNS4B
expression and cleavage, presumably by host proteases, signiﬁcantly
enhanced the inductionof IL-6 and IL-8 transcripts (Fig. 6D). Expressionof
NS4A(-2K) with or without NS2B3(pro) did not induce transcripts of any
of the immunomediators tested while NS4B expressing with NS2B3(pro)
showed slightly reduced induction potential, suggesting that the viral
protease may interfere with NS4B during the induction process (Fig. 6D).
Overall, these data suggest that the induction of DHF-associated
chemokines and cytokines by NS4B is enhanced when NS4AB is cleaved
Fig. 5.Maturation of NS4B via processing of the polyprotein, NS4AB, enhances the production of IL-6 and IL-8. (A and B) The NS4AB gene was cloned into a GFP reporter vector and
co-expressed with NS2B3(pro)-V5 fusion protein in THP-1 cells for detection by ﬂow cytometry. The expression efﬁciencies were measured at 40 h after transfection and expressed
as percent of THP-1 cells expressing DENV-V5-GFP, V5 or GFP fusion proteins. (C)Western blot analysis of THP-1 cells expressing DENV-V5 fusion proteins NS 4AB, 2B3(pro), 4B and
both 4AB and 2B3(pro). β-actin was used as the endogenous control and estimated molecular weight markers (kDa) are shown on the left. (D) Induction of immunomediator
transcripts in THP-1 cells relative to vector controls as determined by qRT-PCR. Bars represent mean±SD of six experimental samples and (*) indicates statistical signiﬁcance at
pb0.05.
33J.F. Kelley et al. / Virology 418 (2011) 27–39by NS2B3(pro), speciﬁcally during 2KNS4B processing by host signalases
and possibly during NS4B localization into the membrane structures
(Miller et al., 2006, 2007; Roosendaal et al., 2006; Umareddy et al., 2006;
Westaway et al., 1997a).
Discussion
It is well established that elevated levels of immunomediators
detected in DHF/DSS patients can adversely alter endothelial cell
integrity leading to plasma leakage and unresolved vascular
permeability (Basu and Chaturvedi, 2008; Green and Rothman,
2006; Leong et al., 2007; Srikiatkhachorn, 2009). However,mechanisms underlying severe DENV immunopathogenesis re-
main elusive. The lack of an animal model to study dengue
immunopathogenesis has led to extensive clinical and in-vitro
studies suggesting that both host and viral factors inﬂuence
elevated circulating immunomediators and severe disease out-
comes (Kurane and Takasaki, 2001; Pang et al., 2007). DENV is
capable of modulating intracellular signaling, such as the IFN
response, or host inﬂammatory responses such as activation of the
transcription factor NF-κB (Mogensen and Paludan, 2001a;
Mogensen and Paludan, 2001b). DHF/DSS is presumed to occur
when the virus outcompetes host antiviral responses and estab-
lishes infection while initiating a robust inﬂammatory response,
Fig. 6. NS4B with the 2K-signal sequence is sufﬁcient to enhance the induction of immunomediators. (A) The DENV genes 2KNS4B and NS4A without the 2K-signal peptide, NS4A
(−2K), were cloned in the V5 reporter vector. (B) Log of V5 mRNA transcripts in THP-1 cells expressing nonstructural plasmids at 40 h after transfection as determined by qRT-PCR.
(C) Western blot analysis of THP-1 cells expressing DENV-V5 fusion proteins NS 2B3(pro) and 2K4B, 2K4B, 4AB and 2B3(pro), 2B3(pro) and 4B, 4B, 2B3(pro) and 4A(−2K), and 4A
(−2K). Estimated molecular weights (kDa) are depicted on the left and β-actin was detected as the endogenous control. (D) Immunomediators' mRNA fold changes as compared to
corresponding V5 controls; GAPDH was used as the endogenous control gene. Bars represent mean±SD of six independent experimental samples and (*) indicates statistical
signiﬁcance at pb0.05.
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Although other investigators have examined DENV initiated IFN
inhibition, very little is known regarding the mechanism by which
the DENV proteins induce DHF/DSS-associated immunomediators.
In this report, we demonstrate that maximum production of immuno-
mediators fromDENV-infectedTHP-1cells correspondswithpeak levels
of secreted infectious virus and cellular viral RNA. Moreover, using a
plasmid construct system that consistently expresses similar levels of
viral gene transcripts and viral-V5 fusion proteins, we demonstrate that
DENV NS4B and NS5 are potent inducers of DHF/DSS-associated
immunomediators in THP-1 cells and that maturation of NS4B via
host protease cleavage of 2KNS4B is a critical step during the observed
induction.
Peak levels of chemokines and cytokines in DENV-infected THP-1 cells
correspond with maximum virus yield
We demonstrate that DENV-infected THP-1 monocytes induce
transcription and secretion of immunomediators such as IL-6, IL-8,
IP-10, TNFα and IFNγ and that peak levels of these chemokine and
cytokines correspond with an increased generation of infectious
virus and viral RNA copy numbers. These data are consistent with
previous reports demonstrating that secreted immunomediator
levels directly correspond with the amount of virus production inTHP-1 cells (Chareonsirisuthigul et al., 2007; Ubol et al., 2008).
Other investigators have demonstrated no infectious virus pro-
duction from DENV-infected THP-1 cells using low passage clinical
isolates and in the absence of enhancing antibodies (Diamond et
al., 2000). This variation may be due to differences in virus
passage, as high-passage virus isolates in-vitro may acquire
dominant mutations that exhibit aberrant phenotypic character-
istics not found in low-passage isolates (Rico-Hesse et al., 1998).
Our data suggest that immunomediator induction occurs during
virus replication when viral RNA copies are elevated. Moreover,
others have demonstrated that the antiviral drug ribavirin inhibits
DENV replication and IL-6 and IL-8 production in a dose
dependent manner (Huang et al., 2000). Regardless, it remains
difﬁcult to pinpoint the precise immunomediator initiation step
due to the dynamic characteristics of virus replication. It is
possible that immunomediator induction corresponds with the
initial translation of input positive-strand viral RNA, negative-
strand viral RNA synthesis, viral protein production or packaging,
and/or secretion of virions. Functional studies demonstrate that
the expression of all NS in THP-1 cells induces the activation of
NFκB, the ubiquitous transcription factor involved in the rapid
production of many chemokines and cytokines (Hershkovitz et al.,
2008). Similarly, expression of NS or NS5 alone in human embryonic
kidney cells induces IL-8 transcription and protein secretion (Medin
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modulates intracellular signaling and initiate immunomediator
induction.
NS5 induces DHF-associated immunomediators in THP-1 monocytes
We demonstrate that NS5 induces high levels of IL-8 as well as IL-
6, IP-10 and IFNγ transcripts and protein secretion in THP-1 cells.
Moreover, it appears that NS5 triggers a rapid and sustained
production of immunomediators as demonstrated by increased
transcript and protein secretion at 24 and 72 h after DENV infection,
and 20 and 40 h after transfection with NS5 constructs, respectively.
NS5 has a potent induction potential as demonstrated by consistent
and equivalent expression levels of all tested viral gene transcripts
and V5 fusion proteins. Although we observed that NS5 localized to
the nucleus and the cytoplasm at 20 and 40 h after transfection, most
NS5 localized to the nucleus (data not shown) consistent with other
reports (Pryor et al., 2007; Rawlinson et al., 2009).
The largest and most highly conserved protein among the
ﬂaviviruses, NS5 serves as the RNA-dependent RNA polymerase
(RdRP) and methyltransferase (Chung et al., 2010; Dong et al., 2010;
Egloff et al., 2007; Harris et al., 2006; Zhou et al., 2007; Zou et al.,
2011). Other investigators have reported that DENV NS5 induces IL-
8 via the activation of the CAAT/enhancer binding protein (c/EBP) and
NFκB (Medin et al., 2005) as it shuttles between nuclear and
cytoplasmic compartments (Pryor et al., 2007; Rawlinson et al.,
2009). Upon positive-sense RNA translation and polyprotein proces-
sing in the cytoplasm, soluble NS5 is thought to undergo phosphor-
ylation allowing the host proteins importin-α/β to bind at two
distinct nuclear localization sequences (NLS) and import NS5 into the
nucleus (Pryor et al., 2007). While hyperphosphorylated NS5 localizes
to the nucleus, its dephosphorylation elicits a conformational change,
allowing exportin-1 to bind and translocate NS5 to the cytoplasm
where it interacts with NS3 as part of the viral replication complex
(Kapoor et al., 1995; Mackenzie et al., 2007; Rawlinson et al., 2009).
Although the function of nuclear NS5 is unclear, greater nuclear
accumulation of NS5 results in decreased IL-8 production and vice
versa (Pryor et al., 2007; Rawlinson et al., 2009), suggesting that the
observed induction of immunomediators occurs when NS5 is
localized in the cytoplasm. Moreover, because the majority of NS5
localizes to the nucleus and only a relatively small amount of NS5 is
required for virus replication in the cytoplasm (Grun and Brinton,
1987; Uchil and Satchidanandam, 2003), it is probable that very low
levels of cytoplasmic NS5 is required to initiate immunomediator
induction. Although the induction mechanisms by NS5 have not been
deﬁned, it is possible that NS5 triggers c/EBP and NFκB signaling
events during NS5/importin interactions in the cytoplasm. However,
this theory remains to be tested. Recent studies demonstrate that NS5
interacts with NS4B in the cytoplasm, and inhibits IFN signaling by
binding and preventing STAT2 phosphorylation (Ashour et al., 2009;
Mazzon et al., 2009; Mazzon et al., 2008), further suggesting that
viral/host protein interactions are important for modulating host
signaling.
NS4B induces DHF-associated immunomediators in THP-1 monocytes
In screening the induction potential of DENVNS inmonocytes, we
demonstrate for theﬁrst time that NS4B induces the secretion of IL-6,
IL-8, IP-10 and IFNγ. The potent NS4B induction pattern is a surprise
given its highly hydrophobic nature and intimate integration within
the ER membrane. Yet, we demonstrate that NS4B has an early and
sustained induction potential as suggestive of its ability to induce IL-
8 at 20 and 40 h after transfection. A highly hydrophobic protein,
NS4B consists of three endoplasmic reticulum (ER) membrane-
spanning segments and may serve as an anchor for the viral
replication complex (Miller et al., 2007; Miller et al., 2006; Welschet al., 2007). NS4B can act as a potent IFN antagonist via interference
and degradation of cellular STAT1 (Munoz-Jordan et al., 2003) which
is synchronized with NS4B maturation via NS4AB cleavage by the
viral protease, NS2B3(pro) (Munoz-Jordan, 2010; Munoz-Jordan et
al., 2005). Interestingly, IFN-β-mediated inhibition of IL-8 expression
requires the presence of STAT1 and STAT2 (Laver et al., 2008). Given
that NS4B maturation inhibits IFN signaling via STAT1 degradation,
we hypothesized that NS4B maturation via NS4AB proteolytic modiﬁ-
cation(s), including host signalase cleavage of 2KNS4B, would lead to
increased levels of IL-8 and possibly other immunomediators. As such,
we tested the induction potential of the processing events involved in
NS4B maturation.
Maturation of NS4B via processing of 2KNS4B enhances the induction of
immunomediators
During polyprotein processing, NS4AB is cleaved by the viral
protease NS2B3(pro), releasing NS4A from NS4B having the 2K-
signal peptide (2KNS4B) before a host signalase cleaves the 2KNS4B
junction in the lumen of the ER to release mature NS4B and allowing
for its integration into the ER membrane (Cahour et al., 1992; Lin et
al., 1993; Miller et al., 2006). To mimic natural NS4B maturation via
polyprotein processing, we co-expressed NS4AB with NS2B3(pro)
and observed that polyprotein cleavage events initiated a more
potent induction of IL-6, IL-8 and IP-10 transcripts than NS4B or NS5
alone. The enhancement appears to be due to NS4AB processing or
maturation and localization of NS4B in the ER, not increased levels of
NS expression as demonstrated by similar expression levels of viral
protein and gene transcripts. Moreover, our data suggest that the 2K-
signal peptide is not required for NS4B induction, yet post-
translational proteolytic cleavage events including host signalase
cleavage of the 2K-peptide fromNS4B is primarily responsible for the
enhancement.
The 2K-signal peptide appears to play an important role during a
variety of intracellular alterations, including anchoring of NS4B to the
ER membrane (Lin et al., 1993). Proteolytic removal of the 2K-peptide
from NS4A during DENV replication induces membrane alterations
that may harbor the viral replication complex (Miller et al., 2007) and
the West Nile virus (WNV) 2K-peptide is important for cytoplasmic
rearrangements, foci development and Golgi trafﬁcking (Roosendaal
et al., 2006). Moreover, IFN inhibition by NS4B appears to require the
presence of the 2K-signal peptide for at least three ﬂaviviruses, DENV,
WNV and yellow fever virus (YFV) (Munoz-Jordan et al., 2005).
Interestingly, the initial 125 amino acid residues of DENV 2KNS4B,
predicted to be located in the cytoplasm between the ﬁrst and second
transmembrane domains, are required for IFN antagonism (Munoz-
Jordan et al., 2005), while the YFV 2K-peptide may be important for
the translocation of cleaved NS4B to the lumen side of the ER
(Chambers et al., 1989).
Given that IFN-β-mediated inhibition of IL-8 production re-
quires the presence of STAT1 and STAT2 (Laver et al., 2008), and
NS5 or processing of 2KNS4B by host proteases is synchronized
with IFN inhibition via STAT1 and STAT2 degradation, it will be
interesting to determine whether both IFN inhibition and immu-
nomediator induction occur in the presence of mature NS4B as
intracellular STAT1 and STAT2 diminish. Overall, we demonstrate
that the viral protease has no intrinsic induction potential alone, yet
it cleaves NS4AB and generates NS4A(-2K) and 2KNS4B, which is
then cleaved by a host protease, perhaps allowing NS4B to reorient
across the ER and initiate IFN inhibition and immunomediator
induction.
Conclusions
Effective host defenses against DENV infection include a robust IFN
response and a rapid production of chemokines and cytokines
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ﬂaviviruses are capable of inhibiting host IFN signaling to establish
productive infections and concurrently promote an overproduction of
immunomediators associated with severe disease. In this report, we
describe DENV-associated immunomediator induction patterns in the
monocytic cell line, THP-1. We have demonstrated that THP-1 cells
sustain excellent viability after electroporation, are permissive to
DENV infection, and thus are an ideal model to examine early events
after infection or expression of DENV NS proteins. We also
demonstrated that NS4B maturation events, speciﬁcally cleavage of
2KNS4B by host proteases, induce signiﬁcantly higher levels of
immunomediators than NS4B or NS5 alone. Therefore, it appears
that maturation of NS4B is important for both IFN inhibition and
immunomediator induction. Given the shared phenotype of IFN
antagonism across the virus family, it is quite possible that IFN
inhibition and immunomediator induction patterns induced during
NS4B maturation are similar for other ﬂaviviruses. Even though
Flavivirus-wide NS4B sequences show divergent and sometimes
negligible genotypic resemblance (Lundin et al., 2003; Qu et al.,
2001), predicted ﬂavivirus NS4B structural topologies, including the
multiple transmembrane and cytoplasmic regions, are strikingly
similar as well as NS4AB cleavage events. Reduced ﬂavivirus protein
expression or polyprotein processing during infection may dampen
virus-induced IFN inhibition and the overproduction of potentially
deleterious immunomediators, minimizing the risk of severe disease.
As such, NS4B may very well be an attractive target for the
development of Flavivirus-wide therapeutic interventions.
Materials and methods
Virus and cell culture
DENV-2 New Guinea C (NGC) strain was obtained from Dr. Duane
Gubler at the University of Hawaii at Manoa. A virus stock was
produced by passaging virus twice in C6/36 cells. Given the extensive
use of the THP-1 cell line by others examining DENV pathogenesis and
due to their permissibility to DEVN infection (Chareonsirisuthigul et
al., 2007; Chen et al., 2009; Hershkovitz et al., 2008; Hober et al., 1996;
Ubol et al., 2008), we chose to work with THP-1 cells in this study. The
THP-1 cells were obtained from the American Type Culture Collection
(ATCC, Rockwell, MD) and were cultured in RPMI-1640 (ATCC)
supplemented with 1% penicillin/streptomycin, 10% heat-inactivated
fetal bovine serum (FBS) (Gibco Labs, Grand Island, NY) and 2-
mercaptoethanol to a ﬁnal concentration of 0.05 mM; cells were
incubated at 37 °C in a 5% CO2 atmosphere. The Vero cells (monkey
kidney epithelial cells) (ATCC) were maintained in M199 and
supplemented with 1% penicillin/streptomycin and 10% FBS.
Infection of THP-1 cells
For infection experiments, 1×106 THP-1 cells were infected with
DENV at MOI-0.1 or -1. After 1.5 h at 37 °C and 5% CO2, the cells were
washed and further culturedwith fresh growthmedia. UV-inactivated
DENV was generated using previously published protocols (Anderson
et al., 1997; Verma et al., 2009). Brieﬂy, DENV was diluted in 500 μL
PBS in a 35-mm culture plate and exposed to UV radiation using a
Stratalinker 2400 device (Stratagene) for 10 min. Inactivation of virus
infectivity was veriﬁed by plaque assay using Vero cells. Mock-
infected control THP-1 cells were infected with UV-inactivated DENV
and for positive controls, THP-1 cells were incubated with 1 μg/mL of
LPS for 1 h, washed and incubated with fresh growth media until
collection at 24 h. Every 24 h, cells and supernatants were collected
while remaining cells were replenished with fresh growth media.
Infectious virus released from infected cells was conﬁrmed by plaque
assay on Vero cells, as described below.Plaque assay
To determine the amount of infectious virus released from DENV-
infected THP-1 cells, plaque assay was conducted using Vero cell
monolayers as described previously (Lambeth et al., 2005). Brieﬂy,
2.5×105 Vero cells per well were seeded in 6-well culture plates
(Corning, Lowell, MA) and incubated for 2 to 3 days until conﬂuent.
Supernatants from DENV-infected THP-1 cells were serially diluted
using 10-fold dilutions in Dulbecco's Modiﬁed Eagles Medium
(DMEM) (Gibco Labs) supplemented with 10% FBS and 100 μL of
each dilution was added to each well of the Vero cells followed by
incubation at 37 °C and 5% CO2 for 1 h with rocking every 15 min.
Three milliliters of primary nutrient agar containing 1% SeaKem® LE
agarose (Lonza, Walkersville, MD) was added to each well and the
plates were incubated for 5 days. Three milliliters of secondary
nutrient agar (primary agar containing 1% neutral red) was added
to each well and the plates were incubated for an additional 2 days
before counting plaques and calculating viral titers (Lambeth et al.,
2005). Titers were expressed as plaque forming units (PFU) per mL.
Construction of plasmids
We employed standard molecular biology techniques to clone the
DENV genes (Sambrook and Russell, 2001). Each primer listed in
Table 1 was designed from the DENV-2 NGC reference genome, NCBI
accession number M29095. All forward primers contain the Kozac
sequence and ATG start codon (Table 1). The PCR step was conducted
using AmpliTaq Gold® DNA polymerase (Applied Biosystems,
Carlsbad, CA) with either the ﬁrst-strand cDNA template (iScript®
cDNA synthesis kit, Bio-Rad Inc., Hercules, CA) synthesized from the
wild-type DENV-2 NGC RNA extracted from stock viral supernatant
using the QIAamp viral RNAmini kit (Qiagen, Hilden, Germany) or the
DENV-2 NGC DNA infectious clone (kindly provided by Barry Falgout,
Food and Drug Administration) (Polo et al., 1997). Following the
manufacturer's protocol, PCR products were cloned into either the
pcDNA3.1/V5-His-TOPO® or the pcDNA3.1/CT-GFP-TOPO® vector
(Invitrogen, Carlsbad, CA) having the CMV promoter for mammalian
expression and detection. Proper gene orientation and identity were
conﬁrmed by DNA sequencing (Greenwood Molecular Biology
Facility, University of Hawaii) and sequence analysis was conducted
using Sequencer® 4.10.1 (Gene Codes Corporation, Ann Arbor, MI).
Selected plasmids were isolated using Cesium Chloride ethidium
bromide equilibrium centrifugation as previously described (Sam-
brook and Russell, 2001).
Transfections
In order to express the DENV-V5 fusion proteins, we transfected
each construct into THP-1 cells using the Neon™ Transfection System
(Invitrogen) after performing a series of optimization protocols as
speciﬁed by the manufacturer. Brieﬂy, 5×105 cells were electropo-
rated with 1 μg of plasmid DNA using 1250 V and 40 ms for 1 pulse.
Cells were directly added to growth media without penicillin/
streptomycin and immediately incubated at 37 °C and 5% CO2. The
supernatants and cells were harvested at 40 h after electroporation
and used for the assays described below.
Flow cytometry
Intracellular expression of DENV-V5 or -GFP fusion proteins was
detected at 40 h after transfection using a Guava EasyCyte ﬂow
cytometer (Guava, Hayward, CA). Cells expressing DENV-V5 proteins
were washed, ﬁxed and permeabilized (Fix & Perm reagents,
Invitrogen) for intracellular labeling with a mouse monoclonal V5
antibody (Invitrogen) diluted 1:500 in PBS and a secondary antibody
against mouse IgG coupled with Alexa Fluor® 594 antibody
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ﬁxed and resuspended in PBS for ﬂow cytometry. Data were analyzed
using FlowJo software version 4.3 and expressed as percent cells
expressing DENV protein.
Quantitative real-time RT-PCR (qRT-PCR)
Total cellular RNA was extracted from DENV-infected-, pDNA-
transfected- and control-THP-1 cells harvested at various time points
using the RNeasy® Plus kit with RNase-Free DNase (Qiagen) as per
manufacturer protocol. cDNAwas synthesized using 1 μg of RNA using
the Bio-Rad iScript® kit in a 20 μL reaction volume. Bio-Rad iCycler
iQ™ Multicolor Real-Time PCR Detection System was employed to
conduct qRT-PCR for quantitation of DENV and V5 copy numbers
using Bio-Rad iQ™ SYBR® Green Supermix, 2 μL of 1:3 diluted cDNA,
and 10 pmol each of forward and reverse primers (Table 2) in a ﬁnal
reaction volume of 20 μL. Thermal cycling reactions for both DENV
and V5 ampliﬁcations were initiated with a denaturing step of 4 min
at 95 °C, followed by 40 cycles of 95 °C (30 s) and 55 °C (30 s for DENV
and 15 s for V5). A standard curve was developed from 10-fold serial
dilutions of linear DENV or V5 gene having known concentrations to
quantitate the dynamic range of detection of 101 to 108 copies per μg
of RNA. Host cellular gene changes relative to the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) housekeeping gene were deter-
mined as previously described (Verma et al., 2006). Primers used to
measure cellular gene changes are listed in Table 2.
Cytokine quantitation
IL-6, IL-8, IP-10, TNFα, VEGF and IFNγ levels were measured in the
supernatants of DENV-infected and pDNA-transfected THP-1 cells
using a Milliplex human cytokine and chemokine 6-plex immunoas-
say kit (Millipore Corp., Billerica, MA) together with the Luminex®
100™ System (Luminex, Austin, TX) to determine mean ﬂuorescent
intensities (MFI) as recommended by the manufacturer. Protein
concentrations were calculated from MFI data using 10-fold serially
diluted standards and Bead View analysis software version 1.0.4
(Millipore). The minimum detectable concentrations were 0.4 pg/mL
for IL-6, 0.3 pg/mL for IL-8, 1.3 pg/mL for IP-10, 0.2 pg/mL for TNFα,
10.1 pg/mL for VEGF and 0.4 pg/mL for IFNγ.
Western blot
Total cellular protein extracts were prepared from THP-1 cells at
40 h after electroporation with DENV-V5 fusion plasmids. Cells were
washed once with cold PBS and extracted with 200 μL of M-PER
mammalian protein extraction buffer (Thermo Scientiﬁc, Rockford, IL)
or NP-40 detergent buffer containing EDTA-free complete protease
inhibitor cocktail (Roche, Indianapolis, IN). Either 20 μL or 50 μg of
total protein was fractionated on a 4–12% gradient SDS polyacryl-
amide gel using the Mini-Protean II (Bio-Rad, Hercules, CA) and then
transferred onto a 0.2 μm nitrocellulose ﬁlter (Bio-Rad Laboratories)
as previously described (Verma et al., 2006). Nonspeciﬁc binding sites
were blocked using 5% FBS in 1× Tris buffered saline with 0.1% Tween
and membranes were incubated at 4 °C overnight with primary V5 or
β-actin antibodies (dilution 1:1000) followed by incubation with
secondary antibodies conjugated to HRP (dilution 1:5000) at room
temperature for 1 h. Protein was detected with enhanced chemilu-
minescence (Amersham ECL, GE Healthcare Limited, Buckingham-
shire, UK) using Amersham ECL Hyperﬁlm (Kodak, Rochester, NY). To
determine the relative intensity (RI) of protein bands, the absolute
intensity of the DENV-V5 protein band was divided by the absolute
intensity of its corresponding β-actin band. Absolute intensities were
calculated using Photoshop by multiplying the given pixel value and
mean intensity of selected bands as previously described (Luhtala and
Parker, 2009).Cell viability assay
To determine the cell viability, 1×106 THP-1 cells were transfected
with plasmid DNA or incubated with 1 μg/mL of LPS for 1 h, washed
and incubated with fresh growth media until collection at 24 h.
Transfected cells were collected at 40 h for measurement of cell
viability. Cell viability was measured using the CellTiter96 AQueous
One Solution Cell Proliferation Assay (Promega, Madison, WI) kit as
per the manufacturers' protocol (Verma et al., 2008).
Statistical analysis
Statistical tests, including paired and unpaired Student's t-tests,
were conducted for qRT-PCR and cytokine and chemokine immuno-
assay using GraphPad InStat version 5.0 (GraphPad Software, San
Diego, CA). Values were expressed asmean±SD of three independent
observations. P values of b0.05 were considered signiﬁcant.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.07.006.
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